Innovating with Impact: Building Successful Businesses from Science-based Discovery
Universities are full of bright, curious individuals asking fundamental questions. What isn’t evident is how breakthroughs are transformed into marketable products and services that combat complex health, environmental, and social challenges. How does an inventor adopt an entrepreneurial mindset, and how can multi-disciplinary expertise create purposeful solutions?
Business development firms, like PureTech Ventures, are masters at turning discovery into profitable healthcare companies. Join Dr. David R. Elmaleh (Associate Professor of Radiology at Harvard Medical School, inventor entrepreneur, and Co-Founder of PureTech) as he shares insights on the role of technology in science-driven businesses. In dialogue with Professor Jui Ramaprasad (Associate Professor of Information Systems at Desautels) he will impart his experience ranging from building new enterprises to resolving conflicts of interest and working on teams.
Doors open at 5:00pm
Leadership Dialogue 5:30 - 7:00pm
Reception to follow 7:00 - 8:00pm
3450 McTavish Street - McGill Faculty Club Ballroom
Please note the event is now sold out, however a livestream option will be made available. Please register for the waitlist to receive details and updates.
About David R. Elmaleh
David R. Elmaleh is a scientist, inventor and entrepreneur, named by Genetic Engineering & Biotechnology News as one of the biotechnology industry's top thirteen serial entrepreneurs for his leadership as scientific founder of multiple companies including Molecular Insight Pharmaceuticals (acquired by Progenics Pharmaceuticals), Mersana Therapeutics, FluoroPharma, and AZTherapies. He is Co-Founder of PureTech Ventures, where he currently serves as a senior advisor.
He is an inventor of three drugs that are in use in man or in late stage clinical trials including: the radiopharmaceutical preparation of 2FDG which has been used in over a million PET imaging procedures, Beta-methyl modified fatty acid (BMIPP) a commercially successful cardiac SPECT agent, and Altropane which has completed Phase III clinical trials.
Doctor Elmaleh holds a PhD in Chemistry from Hebrew University of Jerusalem and is Associate Professor in the Harvard Medical School where he is Director of Contrast Media Chemistry at the Massachussets General Hospital. He is a co-author on over 120 publications and an inventor on dozens of issued and pending patents in a range of disciplines, including molecular imaging and pharmaceuticals.
About Professor Jui Ramaprasad
Jui Ramaprasad is an Associate Professor of Information Systems at theDesautels Faculty of Management at McGill University. She joined Desautels in fall 2009 after receiving her doctorate in Management, Information Systems from the Paul Merage School of Business at the University of California, Irvine. Professor Ramaprasad's research uses large observational datasets and large-scale randomized field experiments to examine the impact of information technology on individuals' social interactions and choices in digital environments, including online music and online dating sites. Underlying this research is her interest understanding the disruptive and enabling power of information technology. She has presented her research at conferences worldwide and published her work in the top Information Systems journals, including Information Systems Research, Management Information Systems Quarterly, and Management Science.
This event is part of the Integrated Management Symposium Series, which invites members of the McGill and Montreal community to explore management through intimate conversations between prominent McGill academics and world leaders in their fields. The series encourages participants to broaden their perspective in order to address the significant ecological, social, and economic challenges facing today's societies.
These free symposia are generously supported by benefactor Marcel Desautels, C.M., LLD’07.
